Works matching IS 10507256 AND DT 2023 AND VI 33 AND IP 9


Results: 17
    1

    Future Meetings.

    Published in:
    Thyroid, 2023, v. 33, n. 9, p. 1133, doi. 10.1089/thy.2023.29163.cal
    Publication type:
    Article
    2
    3
    4

    MERAIODE: A Phase II Redifferentiation Trial with Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer.

    Published in:
    Thyroid, 2023, v. 33, n. 9, p. 1124, doi. 10.1089/thy.2023.0240
    By:
    • Leboulleux, Sophie;
    • Benisvy, Daniele;
    • Taieb, David;
    • Attard, Marie;
    • Bournaud, Claire;
    • Terroir-Cassou-Mounat, Marie;
    • Lacroix, Ludovic;
    • Anizan, Nadege;
    • Schiazza, Aurelie;
    • Garcia, Marie Eve;
    • Ghuzlan, Abir Al;
    • Lamartina, Livia;
    • Schlumberger, Martin;
    • Godbert, Yann;
    • Borget, Isabelle
    Publication type:
    Article
    5

    International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.

    Published in:
    Thyroid, 2023, v. 33, n. 9, p. 1078, doi. 10.1089/thy.2023.0221
    By:
    • Singer, Susanne;
    • Al-Ibraheem, Akram;
    • Pinto, Monica;
    • Iakovou, Ioannis;
    • Østhus, Arild Andre;
    • Hammerlid, Eva;
    • Locati, Laura Deborah;
    • Gamper, Eva;
    • Ignacio, Juan;
    • Jordan, Susan J.;
    • Kiyota, Naomi;
    • Buettner, Matthias;
    • Engesser, Deborah;
    • Canotilho, Rita;
    • Ioannidis, Georgios;
    • Husson, Olga;
    • Gama, Ricardo Ribeiro;
    • Fanetti, Giuseppe;
    • Moss, Laura;
    • Inhestern, Johanna
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Dysfunction of the Salivary and Lacrimal Glands After Radioiodine Therapy for Thyroid Cancer: Results of the START Study After 6-Months of Follow-Up.

    Published in:
    Thyroid, 2023, v. 33, n. 9, p. 1100, doi. 10.1089/thy.2023.0090
    By:
    • Baudin, Clémence;
    • Bressand, Alice;
    • Buffet, Camille;
    • Menegaux, Fabrice;
    • Soret, Marine;
    • Lê, Anh Thu;
    • Cardon, Thomas;
    • Broggio, David;
    • Bassinet, Céline;
    • Huet, Christelle;
    • Armengol, Gemma;
    • Richardson, David B.;
    • Leenhardt, Laurence;
    • Bernier, Marie-Odile;
    • Lussey-Lepoutre, Charlotte
    Publication type:
    Article
    12
    13
    14

    Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.

    Published in:
    Thyroid, 2023, v. 33, n. 9, p. 1119, doi. 10.1089/thy.2022.0707
    By:
    • Wadsley, Jon;
    • Ainsworth, Gemma;
    • Coulson, Amy Beth;
    • Garcez, Kate;
    • Moss, Laura;
    • Newbold, Kate;
    • Farnell, Kate;
    • Swain, Jayne;
    • Howard, Helen;
    • Beasley, Matthew;
    • Weaver, Andrew;
    • Wood, Katie;
    • Marshall, Jennifer;
    • Griffin, Matthew;
    • Pascoe, Abigail;
    • Du, Yong;
    • Taprogge, Jan;
    • Flux, Glenn;
    • Brown, Sarah
    Publication type:
    Article
    15
    16